Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
---|---|---|---|---|---|---|---|
Sun Pharmaceuticals Industries Ltd SUNPHARMA | 1,770.85 | 153.94 | 4,24,382.37 | 863.29 | 0.76 | 5,123.67 | 98.33 |
Divis Laboratories Ltd DIVISLAB | 5,990.3 | 86.67 | 1,59,224.07 | 518 | 0.5 | 2,302 | 513.62 |
Cipla Ltd CIPLA | 1,447.75 | 27.62 | 1,16,942.51 | 1,178.16 | 0.9 | 3,969.86 | 360.73 |
Dr Reddys Laboratories Ltd DRREDDY | 1,337.55 | 23.2 | 1,11,587.52 | 1,882.1 | 0.6 | 6,678.8 | 322.47 |
Mankind Pharma Ltd MANKIND | 2,665.85 | 54.99 | 1,10,215.18 | 634.43 | 0 | 2,529.74 | 334.18 |
No Record Found
Invest wise with Expert advice
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Securities Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.